Cumberland Pharmaceu (CPIX)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
4.77 -0.20 (-4.02%) 04/28/25 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 4.77 unch (unch) 16:00 ET
for Mon, Apr 28th, 2025
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
Cash Flows From Operating Activities | |||||
Net Income | -6,444 | -6,331 | -5,650 | -3,603 | -3,419 |
Depreciation Amortization | 4,903 | 8,280 | 5,328 | 4,606 | 4,749 |
Income taxes - deferred | N/A | N/A | N/A | 0 | 22 |
Accounts receivable | -1,943 | 3,405 | -6,116 | 5,500 | -4,519 |
Other Working Capital | 1,293 | 4,635 | 10,440 | 8,180 | 3,533 |
Other Operating Activity | 1,579 | -3,895 | 4,451 | -8,342 | 5,050 |
Operating Cash Flow | $-612 | $6,094 | $8,453 | $6,342 | $5,415 |
Cash Flows From Investing Activities | |||||
PPE Investments | -67 | -281 | -102 | -104 | -141 |
Net Acquisitions | N/A | N/A | -13,500 | N/A | N/A |
Purchase Of Investment | N/A | N/A | N/A | -200 | 0 |
Purchase Sale Intangibles | -113 | -172 | -1,972 | -251 | -1,973 |
Other Investing Activity | 124 | 176 | -72 | -198 | -1,617 |
Investing Cash Flow | $58 | $-106 | $-13,675 | $-502 | $-1,758 |
Cash Flows From Financing Activities | |||||
Debt Issued | 38,489 | 31,475 | 52,900 | 59,000 | 59,000 |
Debt Repayment | -35,997 | -34,891 | -51,700 | -59,000 | -62,500 |
Common Stock Repurchased | -579 | -741 | -1,053 | -1,387 | -2,652 |
Other Financing Activity | -1,716 | -3,268 | -2,209 | -2,167 | -965 |
Financing Cash Flow | $197 | $-7,425 | $-2,062 | $-3,554 | $-7,116 |
Beginning Cash Position | 18,322 | 19,758 | 27,041 | 24,754 | 28,213 |
End Cash Position | 17,964 | 18,322 | 19,758 | 27,041 | 24,754 |
Net Cash Flow | $-357 | $-1,436 | $-7,283 | $2,287 | $-3,459 |
Free Cash Flow | |||||
Operating Cash Flow | -612 | 6,094 | 8,453 | 6,342 | 5,415 |
Capital Expenditure | -67 | -281 | -102 | -104 | -141 |
Free Cash Flow | -679 | 5,813 | 8,351 | 6,239 | 5,274 |